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Abstract
Objective. To conduct a comprehensive study of patients with ischemic heart disease (IHD) in combination with arterial
hypertension (AH) complicated by chronic heart failure (HF) 2A and 2B, by studying parameters of intracardiac hemodynamics
considering the pressure in the pulmonary artery.
Research results. We examined 120 patients with coronary heart disease in combination with hypertension aged 44 to 90
years old (mean age 72.29 ± 1.66), the majority were men (86.7%). All patients were divided into two groups according to the
degree of heart failure: HF 2A - 54 persons, with HF 2B - 66 people. The groups were compared in age, gender, functional
class of IHD, severity of AH and HF.
Analysis of heart ultrasound showed the following. In IHD in combination with hypertension, complicated by HF 2A, the
pressure in the pulmonary artery rises in an average to 46.46 ± 3.64 mm Hg and it increases in HF 2B to 57.00 ± 5.19 mm
Hg, that corresponding to the average level of pulmonary hypertension (p <0.01); at the same time, the fraction of ejection of
left ventricle in the first patients decreases moderately up to 45.96 ± 2.01%, in others - to 39.93 ± 1.99% (p <0.01).
In patients with IHD in combination with hypertension complicated by chronic heart failure the structural and functional
changes are formed on the side of the left heart, accompanied by an increase in their size due to hypertrophy, formation
of stagnant phenomena, regurgitation, functional state disorders by the restrictive type, progressive systolic and diastolic
dysfunction, increased pressure in the pulmonary artery.
Conclusions. Consideration of pulmonary hypertension, along with other parameters of intracardiac hemodynamics, is an
important component in determining the degree and nature of heart failure, which requires the selection of adequate and
timely therapeutic tactics.
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Problem statement and analysis of the
recent research
In the 21st century, chronic heart failure (CHF) remains one
of the most important problem areas of modern medicine and
it has great social significance due to the widespread, progres-
sive, prognostically unfavorable, course and high economic
losses [1, 2, 8-10].
The European Society of Cardiology in 2016 recommended
an algorithm for diagnosis of CHF, which consists of assessing
the probability of HF (subjective symptoms, anamnesis data,
physical examination, ECG), determination of the plasma
concentration of natriuretic peptide (NUP) and / or echocar-
diography [1].
The echocardiography has the highest sensitivity (from
79 to 100%) and specificity (from 69 to 98%) among non-
invasive methods of diagnosis [4, 7, 11, 12]. It directly pro-
vides information about the volume of chambers of the heart,
systolic and diastolic function, thickness of the myocardial
wall, valves and the presence of pulmonary hypertension (PH).
The study of modern possibilities of detect of the CHF
in patients with ischemic heart disease in combination with
hypertension has shown the following: the heart failure is usu-
ally diagnosed in presence of pronounced morpho-functional
changes that occur due to hemodynamic overload pressure,
rigidity hypertrophied myocardium with increase in connec-
tive tissue matrix, interstitial fibrosis which leads to myocar-
dial ischemia, a decrease in the number of myocytes and sup-
pression of the contractile function of the heart and promotes
the expansion of cavities, remodeling and the development of
heart failure.
At the same time, the presence of secondary pulmonary hy-
pertension, which is formed at the beginning of hemodynamic
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disorders and takes place at all stages of CHF, is practically
not taken into account [5, 6]. Therefore, the issue of early
diagnosis of CHF in patients with ischemic heart disease in
combination with hypertension remains relevant.
Objective. To conduct a comprehensive study of patients
with ischemic heart disease (IHD) in combination with arterial
hypertension (AH) complicated by chronic heart failure (HF)
2A and 2B, by studying parameters of intracardiac hemody-
namics considering the pressure in the pulmonary artery.
1. Material and methods
Diagnosis of IHD in combination with hypertension compli-
cated by heart failure 2A and 2B was established in accor-
dance to the requirements of the Protocols of the Ministry
of Health of Ukraine [4]. The screening program included:
general-clinical, laboratory methods of study, as well as the
study of electrocardiographic and echocardioscopic indicators,
statistical processing of the data.
2. Results and discussion
We examined 120 patients with ischemic heart disease in
combination with hypertension aged 44 to 90 years old (mean
age 72.29 ± 1.66), the majority were men (86.7%) because
studies conducted in the cardiology department of the Military
Medical Center of the Southern region.
All patients were divided into two groups according to the
degree of heart failure: HF 2A - 54 persons, with HF 2B - 66
people. The groups were compared in age, gender, functional
class of IHD, severity of AH and HF.
Heart ultrasound was performed in the positions of echocar-
diography according to the standard protocol [11] with the
calculation of size, volume, speed and other characteristics of
intracardiac hemodynamics.
In both groups, the aortic root dilatation was determined:
in the first group, up to 3.95 ± 0.10 cm, and the second one
to 4.05 ± 0.11 cm, which indirectly indicated the significant
changes in vessels.
Along with this, an increase in the size of the heart in
diameter (DSH) was observed, which in patients of the 1st
group was in the average 11.91 ± 0.39 cm, and of the second
- 12.69 ± 0.46 cm (p<0.05). This was due to the following
changes: first, a significant (p<0.001) increase in the systolic
size of the left ventricle (SS LV) (with HF 2A up to 4.34 ±
0.26 cm, with HF 2B up to 4.77 ± 0.23 cm), and secondly,
the enlarge (p<0.05) of the diastolic size of the left ventricle
(DS LV) (at HF 2A to 5.76 ± 0.21 cm, and at HF 2B to 6.02
± 0.24 cm) (Tab. 1).
In all patients was determined thickening of the walls of
the left heart with an increase in the myocardial mass index
(p<0.01) and hypokinesis of interventricular septum (IVS)
(p<0.05) with the prevalence of these parameters in patients
with HF 2B.
It was noteworthy that the difference in volume changes
between diastole and systole in patients of both groups was
practically the same (1.25 – 1.26 cm) and differed from normal
(1.4 – 2.3) digits. However, this figure was only moderately
lower for HF 2A, because LV hypertrophy was not so signif-
icant, but significantly differed in the group of patients with
HF 2B (p<0.001), given the larger size of ESV and EDV of
LV in these group. This was explained by a reduced ejection
fraction and indicated the formation of restrictive changes in
the heart muscle.
Patients with HF 2B had more attenuated movement of in-
terventricular septum (p<0.05), significantly (p<0.001) lower
ejection fraction (FE) of LV relative to norm and group of
patients with HF 2A and large parameters of end-systolic
(p<0.001) and end-diastolic (p<0.05) volumes (ESV and
EDV), which explained the decrease in the total pumping
function of the heart (Tab. 1).
The received data show the presence of moderate systolic
dysfunction in patients of the first group and expressive in
the second, which was burdened by diastolic dysfunction and
restriction myocardial of LV.
Regurgitation at the mitral valve is absent in healthy, how-
ever, it has been registered in the subjects in varying degrees.
Thus, in the 1st group of observations in 29.6% of patients
regurgitation was clinically insignificant or in a state of com-
pensation (I st.), in 24.1% - in the state of subcompensation
(II st.), the III st. (left ventricular failure) was in 46.3%. In the
2nd group, similar indicators were distributed as follows: I st.
(compensation) was registered in 15.2%; II st. (subcompen-
sation) - in 21.2%; III st. (left ventricular failure) - in 51.5%
and IV st. (dystrophy) in 12.1% of the subjects.
Consequently, hemodynamic overload of LV due to hyper-
tension on the background of ischemic phenomena contributed
to a decrease in contractile function of the myocardium and
regurgitation on the MV, increase in the blood filling of the
left atrium, the difficulty of the outflow of blood from a small
circle of blood circulation and the formation of pulmonary
hypertension (PH).
The pressure in PA in patients with HF 2A (46.46 ± 3.64
mm Hg) exceeded the norm by 1.8 times, and in patients with
HF 2B (57.00 ± 5.19 mm Hg) – 2.2 times (p<0.05). At the
same time, the size of the right ventricle (RV) in patients of the
1st group did not differ from normal, and the 2nd - exceeded
them, with certain regurgitation on tricuspid valve in 81.8%
of cases.
According to the deciphering of the results of the study,
conducted on the background of continued high blood pres-
sure in patients with ischemic heart disease in combination
with hypertension, structural and functional changes in the
heart, remodeling of the myocardium were diagnosed (Tab.
1).
3. Conclusions
Thus, the analysis of heart ultrasound results allowed drawing
the following conclusions:
1. In IHD in combination with hypertension, complicated
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Table 1. Heart ultrasound parameters in patients with ischemic heart disease in combination with hypertension, depending on
the severity of heart failure
TTE parameters Norm HF 2A, n=54 HF 2B, n=66 p
DSH, cm 9-10 11.91±0.39* 12.69±0.46* <0.05
Aortic root diameter, cm up to 3.4 3.88±0.09* 4.05±0.11* <0.05
Diastolic size of LV, cm up to 5.6 5.80±0.18 6.16±0.22* <0.05
Systolic size of LV, cm 3.3-4.2 4.43±0.19 4.98±0.21* <0.001
Diastolic thickness of the posterior wall of LV, cm up to 1.1 1.27±0.03* 1.33±0.05* <0.05
Systolic thickness of the posterior wall of LV, cm 1.3-1.5 1.42±0.03 1.47±0.03* <0.05
End-systolic volume (ESV) of LV 62 87.02±8.76* 110.53±9.57* <0.001
End-diastolic volume (EDV) of LV 160 179.2±11.80* 196.79±11.56* <0.05
Diastolic thickness of interventricular septum, cm up to 1.3 1.41±0.05 1.44±0.04* -
Systolic thickness of interventricular septum, cm 1.2-1.4 1.60±0.04* 1.63±0.03* -
Movement of interventricular septum, cm 0.4-0.6 0.36±0.03* 0.29±0.03* <0.05
Regurgitation on the mitral valve (MV) - 83.4±10.12* 100.0* <0.05
I st. (compensation) - 13.0±9.15* 15.2±8.84*
II st. (subcompensation) - 24.1±11.64* 21.2±10.06*
III st. (LV failure) - 46.3±13.57* 51.5±12.3* <0.05
IV st. (dystrophic) - - 12.1±8.02* <0.001
Left atrium (LA), cm up to 3.9 4.48±0.10* 4.81±0.12* <0.001
Myocardial mass index of LV, g/m2 71-94 127.5±4.58* 134.17±3.10* <0.01
Pressure in the pulmonary artery (PA), mm Hg up to 25 46.46±3.64* 57.00±5.19* <0.05
EFof LV, % 55-65 45.96±2.01* 39.93±1.99* <0.001
Right ventricle (RV), cm up to 3.0 2.80±0.21 3.14±0.12* <0.05
Regurgitation on the tricuspid valve (TV) no no 81.8±9.5* <0.001
Area of right atrium (RA), cm2 up to 15 13.56±0.29 17.28±0.37* <0.001
Notes:
* - the differences compared with the norm are reliable (p<0.05);
p - is the reliability of the differences between HF 2A and 2B.
by HF 2A, the pressure in the pulmonary artery rises in
an average to 46.46 ± 3.64 mm Hg and it increases in
HF 2B to 57.00 ± 5.19 mm Hg., that corresponding to
the average level of pulmonary hypertension (p<0.01);
at the same time, the fraction of ejection of left ventricle
in the first patients decreases moderately up to 45.96 ±
2.01%, in others - to 39.93 ± 1.99% (p<0.01).
2. In patients with IHD in combination with hypertension
complicated by chronic heart failure the structural and
functional changes are formed on the side of the left
heart, accompanied by an increase in their size due
to hypertrophy, formation of stagnant phenomena, re-
gurgitation, functional state disorders by the restrictive
type, progressive systolic and diastolic dysfunction, in-
creased pressure in the pulmonary artery.
3. Consideration of pulmonary hypertension, along with
other parameters of intracardiac hemodynamics, is an
important component in determining the degree and
nature of heart failure, which requires the selection of
adequate and timely therapeutic tactics.
4. Prospects for further researches
Further research aimed at improving the diagnosis of chronic
heart failure, taking into account the degree of pressure in
the pulmonary artery and the fraction of ejection, that devel-
ops in patients with ischemic heart disease in combination
with arterial hypertension, are perspective as they determine
not only the diagnostic but also the prognostic role of the
severity of CHF, contribute to adequate and timely choice of
pharmacological correction.
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